Open original FDA record ↗Recall record
- FDA identifier
- Z-1622-2011
- Company in FDA record
- Fresenius Medical Care Holdings, Inc.
- FDA classification date
- Mar 22, 2011
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
There is an increased risk of an internal blood leak.
Source facts
- Action
- FMCNA notified consignees on 2/16/11 by telephone and follow-up with an Urgent FMCNA Optiflux F250NRe Recall letter via Certified Mail, return Receipt requested. The firm states in the letter that there is an increased risk of an internal blood leak affecting a small percentage of the two lots of dialyzers. They are asking customers to examine their inventory, to discontinue use, and segregate the affected product in a secure place. Customers are to contact their FMCNA Customer Service Team at 1-800-323-5188 for instructions on how to return product. Used dialyzers should not be returned. If there are any questions, Customer Service should be contacted.
- Initiated
- 2011-02-16
- Root cause
- Process control
- Terminated
- 2013-02-12
- Distribution
- Worldwide Distribution -- USA and Canada.
- Recall number
- Z-1622-2011
- Recall status
- Terminated
- CDRH record ID
- 97801
- FDA classified
- 2011-03-22
- Recall event number
- 57947